TPG Biotech is TPG's life science venture capital platform. With more than $770 million in assets currently under management, TPG Biotech focuses on subsectors such as therapeutics, medical devices, and healthcare services. Our team, which includes experienced investors, physicians, scientists, and technical experts, partners with innovative companies and talented entrepreneurs to expand and create new businesses. By leveraging TPG's global network to support portfolio companies, TPG Biotech provides our partners with access to opportunities and operational experts from across the TPG Growth, TPG Capital, and TPG Capital Asia platforms. Since 2002, TPG Biotech has invested in more than 50 life science businesses.
The TPG Biotech partners are Fred Cohen, Heath Lukatch, Eran Nadav, and Heather Preston. To learn more about the team, please click here.